
|Videos|January 7, 2022
Dr. Linehan on advancements in minimally invasive and robotic technologies
Author(s)Urology Times staff
“I think in specialized cases, especially for patients [who] need focal therapy or want focal therapy, or [for whom] you're really trying to minimize any nerve damage or urethral damage…these are excellent therapies,” says Jennifer Linehan, MD.
Advertisement
In this video, Jennifer Linehan, MD, discusses what advancements she foresees in minimally invasive and robotic technologies and how they should be applied to the urologic oncology patient population. Linehan is an associate professor of urology and urologic oncology at the John Wayne Cancer Institute in Santa Monica, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











